8-K: Arteris Reports Record Q2 Revenue, ACV, and RPO

Arteris, Inc. announced strong second quarter 2025 financial results with record Annual Contract Value and Remaining Performance Obligations, alongside updated full-year guidance.

Summary

• Arteris, Inc. reported second quarter 2025 revenue of $16.5 million, marking a 13% year-over-year increase.
• Annual Contract Value (ACV) plus royalties reached a record $69.1 million, up 15% year-over-year.
• Remaining Performance Obligations (RPO) grew to a record $99.3 million, representing a 28% year-over-year increase.
• The company reported a GAAP operating loss of $8.2 million, compared to $7.4 million in Q2 2024.
• Non-GAAP operating loss remained flat at $3.5 million.
• GAAP net loss was $9.1 million, or $0.22 per share, compared to $8.344 million, or $0.22 per share, in Q2 2024.
• Non-GAAP net loss was $4.4 million, or $0.11 per share, compared to $4.392 million, or $0.11 per share, in Q2 2024.
• Arteris secured key customer wins, including AMD licensing FlexGen IP for AI chiplets and Whalechip licensing FlexNoC 5 for high-performance AI computing.
• The company expanded its multi-die solution with broader support for UCIe, Arm AMBA protocols, and collaborations with Synopsys and Cadence, alongside supporting RISC-V ecosystems.
• Arteris introduced Magillem Packaging, a new software product for automating IP packaging and accelerating chiplet/SoC assembly.
• FlexGen received the AI Engineering Innovation Award at the 8th annual AI Breakthrough Awards.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to strong top-line growth, record operational metrics (ACV, RPO), significant customer wins in high-growth markets (AI, autonomous driving), and strategic product expansions, despite widening GAAP losses which are typical for a company investing heavily for future growth.

Positives

• Revenue increased by 13% year-over-year to $16.5 million.
• Annual Contract Value (ACV) plus royalties reached a record $69.1 million, up 15% year-over-year.
• Remaining Performance Obligations (RPO) hit a record $99.3 million, a 28% increase year-over-year, indicating strong future revenue visibility.
• Secured significant design wins with industry leaders like AMD for AI chiplets and Whalechip for data center AI computing.
• Expanded multi-die solution capabilities, enhancing support for key industry standards and ecosystems (UCIe, Arm AMBA, RISC-V).
• Launched Magillem Packaging, a new software product aimed at improving efficiency in chiplet and SoC assembly.
• Received industry recognition with FlexGen winning the AI Engineering Innovation Award.

Negatives

• GAAP operating loss widened to $8.2 million from $7.4 million in the prior year quarter.
• GAAP net loss increased to $9.1 million from $8.344 million in the prior year quarter.
• Free cash flow for the six months ended June 30, 2025, was negative $163 thousand, compared to positive $545 thousand in the same period of 2024.
• GAAP gross margin slightly decreased to 89% from 90% year-over-year.

Risks

• Significant competition from larger companies and third-party providers.
• History of net losses.
• Dependence on semiconductor companies incorporating solutions into their end products and the growth/economic stability of target end markets (automotive, enterprise computing, communications, consumer electronics, industrial).
• Ability to attract new customers and ensure existing customers renew subscriptions.
• The ability of customer end products to achieve market acceptance or growth.
• Ability to sustain or grow licensing revenue.
• Challenges and costs associated with successfully executing research and development efforts.
• Potential for product errors or defects in solutions.
• Risk of failing to offer high-quality customer support.
• Adverse impact from macro-economic conditions, including the imposition of tariffs.
• Effects of geopolitical conflicts, such as the military conflict between Russia and Ukraine and the ongoing conflict in the Middle East.
• Regulatory, operational, financial, and political risks due to dependence on international customers and operations.
• Ability to protect proprietary technology and inventions through patents and other intellectual property rights.
• Potential liabilities or fines resulting from government regulation, including import, export, and economic sanctions laws.
• Risk of network disruptions or security breaches.
• Risks associated with doing business in China, including changes to trade relations between the United States and China.

Future Outlook

Arteris provided estimated third quarter 2025 guidance with ACV plus royalties between $69.5 million and $72.5 million, revenue between $16.8 million and $17.2 million, Non-GAAP operating loss between $3.0 million and $4.0 million, and free cash flow between $0.5 million and $3.5 million. For the full year 2025, the company updated its guidance to ACV plus royalties between $72.0 million and $78.0 million, revenue between $66.0 million and $70.0 million, Non-GAAP operating loss between $10.5 million and $15.5 million, and free cash flow between $1.0 million and $7.0 million.

Management Comments

• Achieved record Annual Contract Value plus royalties of $69.1 million and exited the quarter with $99.3 million in Remaining Performance Obligations, representing a year-over-year increase of 28%.
• Remain confident in Arteris' long-term growth opportunity, supported by a strong product portfolio and pipeline, deepening relationships with leading electronics companies, and continued customer innovation across high-growth markets including AI, autonomous driving, advanced communications, and industrial and consumer applications.

Industry Context

This announcement highlights Arteris' continued growth and strategic positioning within the high-growth semiconductor IP market, particularly in areas like AI, autonomous driving, and advanced communications. The company's focus on multi-die solutions, including support for UCIe and collaboration with major EDA vendors like Synopsys and Cadence, aligns with the industry's shift towards chiplet-based designs. New customer wins with AMD and Whalechip demonstrate strong demand for Arteris' network-on-chip IP in cutting-edge applications, reinforcing its role in accelerating SoC creation for next-generation electronics.

Comparison to Industry Standards

• Arteris' strategic wins with AMD and Whalechip demonstrate its competitive standing in providing high-performance data transport IP for AI and chiplet architectures, aligning with the industry's move towards advanced computing solutions.
• The expansion of multi-die solution support, including UCIe and collaboration with industry leaders like Synopsys and Cadence, positions Arteris at the forefront of chiplet interface technology, a critical area for future semiconductor design.
• Support for RISC-V ecosystems with partners such as Andes, SiFive, and Tenstorrent indicates Arteris' adaptability and relevance across diverse processor architectures, a key trend in the evolving semiconductor landscape.

Stakeholder Impact

• Shareholders: The company reported strong growth in key operational metrics (revenue, ACV, RPO) and strategic customer wins, which could indicate long-term value creation, but also noted widening GAAP losses and negative free cash flow for the six-month period, which may impact short-term profitability expectations.
• Customers: New product offerings like Magillem Packaging and expanded support for industry standards (UCIe, Arm AMBA, RISC-V) enhance the value proposition for existing and potential customers, while new design wins with AMD and Whalechip demonstrate continued adoption of Arteris' IP.
• Employees: Continued investment in research and development and strategic growth initiatives suggest ongoing opportunities and stability within the company, though no specific employee-related impacts were detailed.

Next Steps

• Arteris will host a conference call on August 5, 2025, at 4:30 PM ET to discuss the second quarter 2025 financial results and financial outlook.
• A replay of the webcast will be available in the Investor Relations section of Arteris' website for approximately 30 calendar days after the call.

Key Dates

Recommendation

While Arteris demonstrates strong operational growth with record ACV and RPO, securing key design wins in high-growth sectors like AI and autonomous driving, the widening GAAP losses and negative free cash flow for the six-month period indicate continued unprofitability. For a seasoned investor, this suggests the company is in an investment phase for long-term market capture. The stock is a 'hold' as the growth potential is clear, but profitability remains a future milestone, warranting a cautious approach until a clearer path to sustained positive cash flow and GAAP profitability emerges.

Keywords

Semiconductor IP, System-on-Chip, SoC, Network-on-Chip, NoC, Chiplets, AI, Autonomous Driving, Advanced Communications, Industrial Applications, Consumer Electronics, FlexGen, FlexNoC, Magillem Packaging, UCIe, Arm AMBA, RISC-V, Financial Results, Earnings, Guidance, Software IP